Administration of intestinal mesenchymal stromal cells reduces colitis-associated cancer in C57BL/6J mice modulating the immune response and gut dysbiosis
Pharmacological Research · 2023-09 · 195 · 106891
DOI: 10.1016/j.phrs.2023.106891 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmacological Research, 2023-09. Verfasst von Laura Hidalgo-García und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Center for Biomedical Research (CIBM), University of Granada, 18071 Granada, Spain; Instituto de Investigación Biosanitar…. Hauptthemen laut MEDLINE: Colitis-Associated Neoplasms, Colitis, Inflammatory Bowel Diseases, Mesenchymal Stem Cells. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, Center for Biomedical Research (CIBM), University of Granada, 18071 Granada, Spain; Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), Granada, Spain.
- Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), Granada, Spain; Servicio de Cirugía, Hospital Universitario Virgen de las Nieves, 18012 Granada, Spain.
- Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), Granada, Spain; Servicio de Anatomía Patológica, Hospital Universitario Clínico San Cecilio, 18014 Granada, Spain.
- Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), Granada, Spain; Servicio de Cirugía, Hospital Universitario Clínico San Cecilio, 18016 Granada, Spain.
- Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), Granada, Spain; Servicio Farmacia Hospitalaria, Hospital Universitario Clínico San Cecilio, 18016 Granada, Spain.
- Department of Pharmacology, Center for Biomedical Research (CIBM), University of Granada, 18071 Granada, Spain; Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), Granada, Spain. Electronic address: albar…
Zitieren
APA
Hidalgo-García, L., Ruiz-Malagon, A. J., Huertas, F., Rodríguez-Sojo, M. J., Molina-Tijeras, J. A., Diez-Echave, P., Becerra, P., Mirón, B., Morón, R., Rodríguez-Nogales, A., Gálvez, J., Rodríguez-Cabezas, M. E., & Anderson, P. (2023). Administration of intestinal mesenchymal stromal cells reduces colitis-associated cancer in C57BL/6J mice modulating the immune response and gut dysbiosis. Pharmacological Research, 195, 106891. https://doi.org/10.1016/j.phrs.2023.106891
Vancouver
Hidalgo-García L, Ruiz-Malagon AJ, Huertas F, Rodríguez-Sojo MJ, Molina-Tijeras JA, Diez-Echave P, et al. Administration of intestinal mesenchymal stromal cells reduces colitis-associated cancer in C57BL/6J mice modulating the immune response and gut dysbiosis. Pharmacological Research. 2023;195:106891. doi:10.1016/j.phrs.2023.106891
BibTeX
@article{HidalgoGarca2023,
author = {Hidalgo-García, Laura and Ruiz-Malagon, Antonio Jesús and Huertas, Francisco and Rodríguez-Sojo, María Jesús and Molina-Tijeras, José Alberto and Diez-Echave, Patricia and Becerra, Patricia and Mirón, Benito and Morón, Rocío and Rodríguez-Nogales, Alba and Gálvez, Julio and Rodríguez-Cabezas, María Elena and Anderson, Per},
title = {Administration of intestinal mesenchymal stromal cells reduces colitis-associated cancer in C57BL/6J mice modulating the immune response and gut dysbiosis},
journal = {Pharmacological Research},
year = {2023},
volume = {195},
pages = {106891},
doi = {10.1016/j.phrs.2023.106891}
}
EUVIMED